Could the Whole CRISPR Patent Kerfuffle Have Been Completely Avoided?
By Kristen V. Brown,
Gizmodo
| 11. 17. 2017
For the better part of the last three years, the introduction of the most powerful gene editing technology ever invented has been marred by a nasty patent battle. The two groups of scientists involved, each contributing significantly to the future of genetic engineering, are pitted against each other in a bitter contest for glory and fortune.
In one corner: UC Berkeley, which argued that seminal 2012 work revealing that a bacterial immune system called CRISPR could be repurposed to edit genes ultimately paved the way for CRISPR to be used to genetically alter animal DNA. In the other corner: The Broad Institute of Harvard and MIT, which six months later actually adapted CRISPR to engineer plant, animal and human cells. At issue: Who deserves credit for the original recipe that led to using CRISPR-Cas9 to edit mammalian DNA.
In February, a US Patent Office appeal board raised the Broad Institute’s arm in victory. Since then, this US case has been stuck in appeals within the Federal Circuit (in Europe, the question of who will ultimately win this patent battle...
Related Articles
By Jim Kozubek, Scientific American | 01.21.2019
A Chinese researcher recently disrupted the CCR5 gene, which builds a protein that acts as an entryway that HIV uses to gain entry to T-cells, allegedly creating the world’s first genetically engineered baby. Chinese officials moved swiftly to condemn the...
By Antonio Regalado, MIT Technology Review | 02.07.2019
Officials at Stanford University have opened an investigation into what several high-profile faculty members knew about a Chinese effort to create gene-edited babies led by a onetime researcher at the California school, He Jiankui.
The investigation, according to people familiar...
By The Editorial Board, The New York Times | 01.28.2019
Scientists quickly condemned the Chinese researcher who altered the DNA of at least two embryos to create the world’s first genetically edited babies, defying a broad consensus against hereditary tinkering.
But as The Times reported last week, the global scientific community is...
By Shobita Parthasarathy, Nature | 10.23.2018
Next month, researchers, policymakers, ethicists and social scientists will meet in Hong Kong for the second International Summit on Human Gene Editing.
Since the first summit, held in Washington DC nearly three years ago, researchers have continued to apply the...
